Unknown

Dataset Information

Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.


ABSTRACT:

Purpose

Leiomyosarcomas (LMS) are clinically and molecularly heterogeneous tumors. Despite recent large-scale genomic studies, current LMS risk stratification is not informed by molecular alterations. We propose a clinically applicable genomic risk stratification model.

Experimental design

We performed comprehensive genomic profiling in a cohort of 195 soft tissue LMS (STLMS), 151 primary at presentation, and a control group of 238 uterine LMS (ULMS), 177 primary at presentation, with at least 1-year follow-up.

Results

In STLMS, French Federation of Cancer Centers (FNCLCC) grade but not tumor size predicted progression-free survival (PFS) or disease-specific survival (DSS). In contrast, in ULMS, tumor size, mitotic rate, and necrosis were associated with inferior PFS

SUBMITTER: Dermawan JK 

PROVIDER: S-EPMC11096044 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature